Transcatheter heart valve for replacing natural mitral valve

Information

  • Patent Grant
  • 10470876
  • Patent Number
    10,470,876
  • Date Filed
    Tuesday, November 8, 2016
    7 years ago
  • Date Issued
    Tuesday, November 12, 2019
    4 years ago
Abstract
Embodiments of prosthetic valves for implantation within a native mitral valve are provided. A prosthetic valve may comprise a radially compressible main body and a one-way valve portion. The prosthetic valve may further comprise one or more ventricular anchors coupled to the main body and disposed outside of the main body. The ventricular anchors may be configured such that a reduced profile of the prosthetic valve is possible. A space may be provided between an outer surface of the main body and the ventricular anchors for receiving native mitral valve leaflets. The prosthetic valve may include an atrial sealing member adapted for placement above the annulus of the mitral valve. Methods and devices for receiving the native mitral valve leaflets between the ventricular anchors and the main body are described.
Description
FIELD

The field of the present disclosure generally relates to prosthetic devices for repairing and/or replacing native heart valves. More particularly, the field of the invention relates to prosthetic mitral valves having ventricular anchors that contribute to a relatively small crimp profile and are better suited to withstand stresses and strains during delivery into a patient.


BACKGROUND

Prosthetic valves may be used to treat cardiac valvular disorders. Native heart valves, such as aortic, pulmonary, tricuspid, and mitral valves, serve critical functions in assuring a forward flow of an adequate supply of blood through the cardiovascular system. Heart valves can be rendered less effective by congenital malformations, inflammatory processes, infectious conditions, or diseases. Damage to the valves typically results in serious cardiovascular compromise or death. For many years the definitive treatment for heart valve disorders has been surgical repair or replacement of valves by way of open heart surgery. Such surgeries, however, are highly invasive and prone to many complications. As such, elderly and frail patients with defective heart valves often go untreated.


Transvascular techniques have been developed for introducing and implanting a prosthetic heart valve using a flexible catheter in a manner that is much less invasive than open heart surgery. For example, a prosthetic valve may be mounted in a crimped state on an end portion of a flexible catheter and advanced through a blood vessel of a patient until the valve reaches an implantation site of a defective native valve. The prosthetic valve may then be expanded to a functional size at the implantation site such as by inflating a balloon on which the valve is mounted.


Another technique for implanting a prosthetic aortic valve is a transapical approach where a small incision is made in the chest wall of the patient and the catheter is advanced through the apex (i.e., bottom tip) of the heart. Transapical techniques are disclosed in U.S. Patent Application Publication No. 2007/0112422, which is hereby incorporated by reference. As with the transvascular approach, the transapical approach may include a balloon catheter having a steering mechanism for delivering a balloon-expandable prosthetic heart valve through an introducer to a defective native valve. The balloon catheter may include a deflecting segment just proximal to the distal balloon to facilitate positioning of the prosthetic heart valve in a proper orientation within an aortic annulus.


The above techniques and others provide numerous options for high operative risk patients with aortic valve disease to avoid the consequences of open heart surgery and cardiopulmonary bypass. While devices and procedures for aortic valves exist, such catheter-based procedures are not necessarily applicable to the mitral valve due to distinct differences between aortic and mitral valves. For example, the mitral valve has a complex subvalvular apparatus, known as chordae tendineae, which are not present in the aortic valve and can complicate valve delivery and placement.


When the native mitral valve fails to function properly, a prosthetic valve replacement may help restore proper functionality. Compared to the aortic valve, however, which has a relatively round and firm annulus, the mitral valve annulus can be relatively less firm and more unstable. Consequently, it may not be possible to secure a prosthetic valve that is designed for the aortic valve within the native mitral valve annulus by relying solely on friction from the radial force of an outer surface of a prosthetic valve pressed against the native mitral annulus. Accordingly, it may be beneficial to add ventricular anchors to prosthetic mitral valves to help secure the prosthetic valve within the native mitral valve annulus.


However, the addition of ventricular anchors may result in a relatively large crimp profile, including as large as 40 F (i.e., French Gauge). Further, a connection area between the ventricular anchors and the prosthetic valve may experience a relatively high degree of strain during crimping which may give rise to damage to the prosthetic valve during delivery into a patient. A prosthetic mitral valve having ventricular anchors that do not result in an overly large crimp profile or do not increase the size of the crimp profile and comprising a connection area that is better suited to withstand stresses and strains during delivery into the patient.





BRIEF DESCRIPTION OF THE DRAWINGS

The drawings refer to embodiments of the present disclosure in which:



FIG. 1 illustrates a cross-sectional view of a human heart;



FIG. 2 illustrates another cross-sectional view of the human heart, focusing on a mitral valve region;



FIG. 3 illustrates a schematic view of a native mitral valve anatomy, showing mitral leaflets attached to papillary muscles by way of chordae tendineae;



FIG. 4A illustrates a diagram of a native mitral valve, including Carpentier nomenclature;



FIG. 4B illustrates a native mitral valve with a gap between the leaflets;



FIG. 5 illustrates a cross-sectional view of the heart, showing a frame of a prosthetic valve implanted in the mitral valve region;



FIG. 6 illustrates an isometric view of an exemplary embodiment of a prosthetic mitral valve comprising ventricular anchors;



FIG. 7 illustrates an isometric view of an exemplary embodiment of a prosthetic valve comprising anchors formed as wire spiral paddles having a wide oval shape;



FIG. 8 illustrates an isometric view of an exemplary embodiment of a prosthetic valve comprising anchors formed as wire spiral paddles having a substantially circular shape;



FIG. 9 illustrates an isometric view of a prosthetic valve crimped into a forward compressed state;



FIG. 10 illustrates an isometric view of a prosthetic valve crimped into a backward compressed state;



FIG. 11 illustrates a side view of a prosthetic valve crimped into a backward compressed state;



FIG. 12 illustrates anchors formed as wire spiral paddles shaped into inwardly-directed helixes;



FIG. 13 illustrates a wire spiral paddle shaped into an inwardly-directed helix before being moved into a pressed relationship with a wall of a valve;



FIG. 14 illustrates an isometric view of an exemplary embodiment of a prosthetic valve adapted for implantation within the native mitral valve region of the human heart;



FIG. 15 illustrates a front view of the prosthetic valve of FIG. 14 comprising an interlaced mechanism;



FIG. 16 illustrate a close-up view of the interlaced mechanism of FIGS. 14-15;



FIG. 17 illustrates a side view of the prosthetic valve of FIG. 14 crimped into a compressed state suitable for residing within a delivery system capsule;



FIG. 18 illustrates a front view of the prosthetic valve of FIG. 14 crimped into a compressed state suitable for residing within a delivery system capsule;



FIG. 19 illustrates a side view of a frame partially expanded with expanded anchor portions being positioned to engage with native leaflets so as to anchor the prosthetic valve of FIG. 14 within the mitral valve region of the heart;



FIG. 20 illustrates a front view of a frame partially expanded with expanded anchor portions being positioned to engage with native leaflets so as to anchor the prosthetic valve of FIG. 14 within the mitral valve region of the heart;



FIG. 21 illustrates a side view of native leaflets engaged with an interlaced anchoring system of a prosthetic valve;



FIG. 22 illustrates a front view of native leaflets engaged with an interlaced anchoring system of a prosthetic valve;



FIG. 23 illustrates an isometric view of native leaflets engaged with an interlaced anchoring system of a prosthetic valve;



FIG. 24 illustrates a cut-away interior view of native leaflets engaged with an interlaced anchoring system of a prosthetic valve;



FIG. 25 illustrates an isometric view of an exemplary embodiment of a prosthetic valve configured to exhibit a relatively small profile when crimped into a compressed state, e.g., such that the anchors do not add to the profile;



FIG. 26 illustrates an isometric view of an exemplary embodiment of a main body of a prosthetic valve configured to pinch native leaflets in a direction that is parallel to the orientation of the leaflets;



FIG. 27 is a schematic illustrating a native leaflet being pinched in a direction that is parallel to the orientation of the leaflet;



FIG. 28 is a schematic illustrating a native leaflet being gripped by way of a locking mechanism;



FIG. 29 is a schematic illustrating a soft material layer that operates as a cushion to reduce instances of frictional abrasions or tearing of a native leaflet;



FIG. 30 illustrates an isometric view of an exemplary embodiment of a prosthetic valve configured to be implanted within the mitral valve region of the heart;



FIG. 31 illustrates an alternate view of the anchor of the prosthetic valve shown in FIG. 30 with the anchor shown in an extended state, e.g., the top of the anchor extends in a direction generally opposite from the bottom ends of the anchor;



FIG. 32A illustrates a side view of a side portion of an exemplary embodiment of a prosthetic valve 220 configured to be implanted within the mitral valve region of the heart;



FIG. 32B illustrates a front view of an exemplary embodiment of a prosthetic valve 220 configured to be implanted within the mitral valve region of the heart;



FIG. 33 illustrates a prosthetic valve in an expanded state comprising a height difference between pivots receiving first and second ends of a ventricular anchor;



FIG. 34 illustrates the prosthetic valve of FIG. 33 in a compressed state wherein the pivots are aligned and the ventricular anchor is freely moveable and is shown extended;



FIG. 35 illustrates an isometric view of an exemplary embodiment of a prosthetic valve comprising multi-wire ventricular anchors;



FIG. 36 is a table showing a relationship between wire thickness and strain induced within the wire due to bending;



FIG. 37 is a graph illustrating a relationship between wire diameter and pinching force of ventricular anchors;



FIG. 38A illustrates an isometric view of an exemplary embodiment of an anchor formed as a T-shaped paddle in a crimped configuration to minimize risk of damage to native leaflets during positioning within the mitral valve region of the heart;



FIG. 38B illustrates an isometric view of the T-shaped paddle of FIG. 38A in an open configuration for pinching the native leaflets;



FIG. 39A illustrates an isometric view of an exemplary embodiment of an anchor formed as a T-shaped paddle in a folded configuration to minimize risk of damage to native leaflets during positioning within the mitral valve region of the heart;



FIG. 39B illustrates an isometric view of the T-shaped paddle of FIG. 39A in an open configuration for pinching the native leaflets;



FIG. 40 illustrates an exemplary embodiment of a ventricular anchor/paddle for use on a prosthetic valve that illustrates padding separated from the wire forming the anchor/paddle and shows a pull wire for moving the padding; and



FIG. 41 illustrates the ventricular anchor/paddle of FIG. 40 with the pull wire tensioned to pull the padding into close contact with and surrounding the wire forming the anchor/paddle.





While the present disclosure is subject to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and will herein be described in detail. The invention should be understood to not be limited to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure.


DETAILED DESCRIPTION

In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present disclosure. It will be apparent, however, to one of ordinary skill in the art that the invention disclosed herein may be practiced without these specific details. In other instances, specific numeric references such as “first leaflet,” may be made. However, the specific numeric reference should not be interpreted as a literal sequential order but rather interpreted that the “first leaflet” is different from a “second leaflet.” Thus, the specific details set forth are merely exemplary. The specific details may be varied from and still be contemplated to be within the spirit and scope of the present disclosure. The term “coupled” is defined as meaning connected either directly to the component or indirectly to the component through another component. Further, as used herein, the terms “about,” “approximately,” or “substantially” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein.


Described herein are embodiments of prosthetic valves and components thereof that are primarily intended to be implanted at the mitral valve region of a human heart. The prosthetic valves may be used to help restore and/or replace the functionality of a defective native mitral valve. However, while the disclosure focuses primarily on mitral valves the concepts, anchors/paddles, etc. are not limited to mitral valves and may be used on prosthetic valves, stents, etc. for use in other regions of the heart or parts of the body.



FIGS. 1 and 2 illustrate relevant portions of the human heart. A healthy heart has a generally conical shape that tapers to a lower apex 38. The heart is four-chambered and comprises a left atrium 4, a right atrium 26, a left ventricle 6, and a right ventricle 28. The left and right sides of the heart are separated by a wall generally referred to as a septum 30. The left ventricle 6 is bounded by the septum 30 and a wall 20 of the left ventricle. A mitral valve 2 of the human heart connects the left atrium 4 to the left ventricle 6. The mitral valve 2 has a very different anatomy than other native heart valves, such as an aortic valve 14.


The mitral valve 2 includes an annulus portion 8, which is an annular portion of the native valve tissue surrounding the mitral valve orifice, and a pair of cusps, or leaflets, 10, 12 extending downward from the annulus 8 into the left ventricle 6. The mitral valve annulus 8 can form various shapes, e.g., an oval, “D” shape, saddle shape, bean shape, or some other out-of-round cross-sectional shape having major and minor axes. The anterior leaflet 10 can be larger than the posterior leaflet 12, as shown schematically in FIGS. 4A-4B, forming a generally “C” or curved shaped boundary between the abutting free edges of the leaflets (e.g., when they are closed together). FIG. 4B shows the native mitral valve 2 with a slight gap 3 between the leaflets 10, 12, such as with a defective native mitral valve that fails to completely close (e.g., a mitral valve with an enlarged annulus), which can lead to mitral regurgitation and/or other undesirable conditions.


When operating properly, the anterior leaflet 10 and the posterior leaflet 12 function together as a one-way valve to allow blood to flow only from the left atrium 4 to the left ventricle 6. The left atrium 4 receives oxygenated blood from the pulmonary veins 32. When the muscles of the left atrium 4 contract and the left ventricle 6 dilates, the oxygenated blood that is collected in the left atrium 4 flows into the left ventricle 6. When the muscles of the left atrium 4 relax and the muscles of the left ventricle 6 contract, the increased blood pressure in the left ventricle urges the two leaflets together, thereby closing the one-way mitral valve so that blood cannot flow back to the left atrium and is instead expelled out of the left ventricle through the aortic valve 14.


To prevent the two leaflets 10, 12 from prolapsing under pressure and folding back through the mitral annulus 8 toward the left atrium 4, a plurality of fibrous cords called chordae tendineae 16 (generally referred to as “chordae” herein) tether the leaflets 10, 12 to papillary muscles in the left ventricle 6. Referring to FIGS. 3 and 4A, chordae 16 are attached to and extend between the postero-medial papillary muscle 22 and the postero-medial margins of both the anterior leaflet 10 and the posterior leaflet 12 (A1 and P1 areas, respectively, as identified by Carpentier nomenclature). Similarly, chordae 16 are attached to and extend between the antero-lateral papillary muscle 24 and the antero-lateral margins of both the anterior leaflet 10 and the posterior leaflet 12 (A3 and P3 areas, respectively, as identified by Carpentier nomenclature). As shown in FIG. 3, the A2 and P2 areas are relatively free of chordae attachment points and provide a region where a prosthetic mitral valve may be anchored. In addition, the organization of the chordae provides an approach path to deliver a prosthetic mitral valve with minimal risk of chordae entanglement.


When the native mitral valve fails to function properly, a prosthetic valve replacement may help restore proper functionality. Compared to the aortic valve, however, which has a relatively round and firm annulus, the mitral valve annulus can be relatively less firm and less stable. Consequently, it may not be possible to secure a prosthetic valve that is designed primarily for the aortic valve within the native mitral valve annulus by relying solely on friction from the radial force of an outer surface of a prosthetic valve pressed against the native mitral annulus. Accordingly, anchors/paddles (e.g., ventricular anchors/paddles) may be added to or used with prosthetic mitral valves, where the anchors operate instead of, or in addition to, radial friction forces, so as to secure the prosthetic valve within the native mitral valve annulus, e.g., as shown in FIG. 5.


In addition to providing an anchoring means for the prosthetic valve, the ventricular anchors can also remodel the left ventricle 6 to help treat an underlying cause of mitral regurgitation—left ventricle enlargement/dilation. The ventricular anchors can pull the native mitral valve leaflets 10, 12 closer together and toward the left atrium and, via the chordae 16, thereby pull the papillary muscles 22, 24 closer together, which can positively remodel the ventricle acutely and prevent the left ventricle from further enlarging. Thus, the ventricular anchors can also be referred to as tensioning members or reshaping members.



FIG. 5 illustrates a cross-sectional view of the human heart showing an exemplary prosthetic valve 100, according to one embodiment, implanted in the native mitral valve region of the heart to replace the functionality of the native mitral valve 2. FIG. 6 illustrates an isometric view of an exemplary embodiment of a prosthetic valve 100 that is substantially similar to the prosthetic valve shown in FIG. 5. The prosthetic valve 100 comprises a frame 102 and a valve structure 104 supported by and/or within the frame. The valve structure 104 may include a plurality of prosthetic leaflets 106 for regulating a flow of blood in one direction through the prosthetic valve 100. As shown in FIGS. 5-6, the frame 102 generally comprises a tubular main body 122, and an anterior ventricular anchor/paddle 146 and a posterior ventricular anchor/paddle 148 extending from a ventricular end 130 of the main body and optionally atrial sealing members/bodies 124 extending radially outward from an atrial end 132 of the main body. When the frame 102 is implanted in the native mitral valve region of the heart, as shown in FIG. 5, the main body 122 is positioned within the native mitral valve annulus 8 with the ventricular end 130 of the main body 122 being a lower outlet end, the atrial end 132 of the main body 122 being an upper inlet end, the ventricular anchors 146, 148 being located in the left ventricle 6, and the atrial sealing members 124 being located in the left atrium 4.


The frame 102 may be made of a wire mesh or another type of stent frame and may be radially collapsible and expandable between a radially expanded state and a radially compressed state so as to enable delivery and implantation at the mitral valve region of the heart, or within another native heart valve. The wire mesh or stent frame may include metal wires or struts arranged in a lattice pattern, such as a saw-tooth or zig-zag pattern shown in FIGS. 5-6 for example, but other patterns may also be used. The frame 102 may comprise a shape-memory material, such as Nitinol for example, to enable self-expansion from the radially compressed state to the expanded state. In some embodiments, the frame 102 may be plastically expandable from a radially compressed state to an expanded state by an expansion device, such as an inflatable balloon (not shown) for example. Such plastically expanding frames may comprise stainless steel, chromium alloys, and/or other suitable materials. The frames could also be partially self-expandable, e.g., the anchors/paddles may be self-expandable, while the main body of the frame may require an expansion device to expand. The various anchors/paddles shown or described herein may be used with a variety of different frames, e.g., any frames shown or described herein or other frames. The various anchors/paddles shown or described herein may also comprise a shape-memory material, such as Nitinol, e.g., to enable the anchor/paddle to move from a compressed or delivery configuration to a different deployed configuration. The various anchors/paddles and/or the exterior surfaces of the various frames described or shown herein could also be textured, coated, or otherwise have a high friction surface to help prevent the prosthetic valve from slipping off the native leaflets and/or dislodging.


Additional details regarding components and assembly of prosthetic valves, as well as techniques for mounting leaflets to the frame, are described, for example, in U.S. Patent Application Publication No. 2009/0276040 A1, U.S. patent application Ser. No. 12/393,010, and U.S. Pat. No. 8,449,599, entitled “Prosthetic Valve for Replacing Mitral Valve,” issued on May 28, 2013, the entirety of each of which is incorporated by reference herein.


As best shown in FIG. 5, the anterior and posterior ventricular anchors 146, 148 extend from the main body 122 of the frame 102, such as from the ventricular end 130 of the main body. The ventricular anchors 146, 148 function to retain the frame 102, with or without the valve structure 104, within a native valve region of the heart. In the embodiment shown in FIGS. 5-6, the frame 102 comprises two diametrically opposed ventricular anchors 146, 148 that function to secure the frame 102 to the anterior and posterior mitral leaflets 10, 12, respectively, when the frame 102 is implanted in the mitral valve region. In some embodiments, the frame 102 may comprise one, two, three, four, or more ventricular anchors/paddles, which may be angularly spaced around the main body 122 of the frame, or multiples may be stacked or lined up in the same region (e.g., as discussed with respect to the embodiment in FIG. 35).


When the frame 102 is in an expanded state, as shown in FIGS. 5-6, the geometry of the frame causes the ventricular anchors/paddles 146, 148 to be pressed toward the outer surface of the main body 122. When the frame 102 is radially compressed to a compressed, or crimped, state, the space or gap between the ventricular anchors 146, 148 and the outer surface of the main body 122 may increase, thereby facilitating engagement of the prosthetic valve 100 with the leaflets 10, 12. While the main body 122 and the atrial sealing member 124 are in the crimped state, the frame 102 may be inserted into the mitral valve orifice such that the spaced apart ventricular anchors 146, 148 respectively wrap around the leaflets 10, 12 and extend upward between the leaflets and the walls of the left ventricle 6. With reference to FIG. 5, the anterior ventricular anchor 146 may be located behind the anterior leaflet 10 and the posterior ventricular anchor 148 may be located behind the posterior leaflet 12. With reference to FIGS. 3 and 4A, the two ventricular anchors are desirably located behind the respective leaflets near the middle portions of the leaflets A2, P2 about midway between commissures 36 where the two leaflets meet. These middle portions A2, P2 of the leaflets 10, 12 are desirable ventricular anchor locations because the chordae tendineae 16 attachments to the leaflets are sparser in these locations compared to locations nearer to the commissures 36. The anchors (e.g., ventricular anchors 146, 148) may contribute to a relatively large or larger profile of the prosthetic valve 100 when in the compressed state (i.e., the anchors can add diameter to the valve).



FIGS. 7-8 illustrate an exemplary embodiment of a prosthetic valve 160 comprising ventricular anchors in the form of wire spiral paddles 164 configured to anchor the valve to the native leaflets 10, 12. In the embodiment illustrated in FIG. 7, the wire spiral paddles 164 have a relatively wide oval shape, while the wire spiral paddles 164 illustrated in FIG. 8 comprise a substantially circular shape. The wire spiral paddles 164 generally are comprised of a wire extending from the ventricular end 130 of the main body 122 and coiled into a helix. When the helix presses against the exterior of the main body 122, the helix can flatten into the wire spiral paddles as shown in FIGS. 7-8.


The wire spiral paddles 164 may comprise any number of turns, and may comprise various pitches and/or arrangement of turns so as to control the pressure and force distribution applied to the native leaflets 10, 12. The wire spiral paddles 164 are configured to apply a relatively uniform distribution of force onto the leaflets 10, 12 so as to provide relatively better anchoring of the prosthetic valve 160 within the heart. As will be appreciated, a substantially uniform force distribution operates to reduce pressure concentrations applied to the leaflets 10, 12, and thus reduces a risk of native leaflet abrasions once the prosthetic valve 160 is implanted within the mitral valve region of the heart. Further, the substantially uniform force applied by the anchors (e.g., by wire spiral paddles 164) to the native leaflets 10, 12 generally reduces strain on the anchors, thereby reducing a risk of material fatigue arising with the prosthetic valve 160. The wire spiral anchors/paddles 164 (as well as the other anchors/paddles described herein) may be coated with a soft material or be wrapped or surrounded in a cloth pouch or other padding (e.g., to help protect the native mitral valve leaflets and possibly to provide added friction, for example, with a textured surface or high friction surface). For example, the entire spiral may be wrapped in a cloth pouch (e.g., a wide pouch that surrounds all portions of the spiral in the same area) or a cloth sleeve that runs along the length of the paddle (e.g., the cloth sleeve may be long and narrow and may itself spiral with each turn of the wire).


As mentioned above, the wire spiral paddles 164 significantly reduce the crimp profile of the frame 102. FIG. 9 illustrates an isometric view of the prosthetic valve 160 crimped into a forward compressed state. In the forward compressed state, the wire spiral paddles 164 are shown stretched into a long wavy wire shapes within a delivery system capsule for delivery into the heart. When the wire spiral paddles 164 exit the delivery system capsule, the long wavy wires return to the paddle shape shown in FIGS. 7-8, e.g., the paddles 164 may be of a shape-memory material that will automatically return to the desired shape upon being deployed. In the forward compressed state, the entire paddle may be contained in a cloth sleeve (e.g., a long narrow sleeve; a skirted sleeve). In one embodiment, the cloth sleeve may also move into the spiral shape as the paddle regains the spiral shape when deployed.



FIGS. 10-11 illustrate respective isometric and side views of the prosthetic valve 160 crimped into a backward compressed state. In the backward compressed state, the anchors or wire spiral paddles 164 are pressed against the exterior surface of the main body 122 within the delivery system capsule, resulting in an elongate oval shape of the paddles. When the wire spiral paddles 164 exit the delivery system capsule, however, the paddles may return or change to a generally circular or wide oval shape as shown in FIGS. 7-8. Although the backward compressed state gives rise to relatively small strains on the paddles, the forward compressed state advantageously reduces the crimp profile of the prosthetic valve 160 more than the backward compressed state.


As mentioned above, the wire spiral paddles 164 generally are comprised of a wire extending from the ventricular end 130 of the main body 122 and coiled into a helix. When the helix presses against the exterior of the main body 122, the helix can flatten into the wire spiral paddles shown in FIGS. 7-8. In some embodiments, the wire spiral paddles 164 may comprise separate components that are fastened to the frame 102 during assembly of the prosthetic valve 160. In some embodiments, the wire spiral paddles 164 may comprise portions of a single, laser cut frame. As will be appreciated, using a single piece of material to fabricate the frame 102 and the paddles 164 enables the paddles to be advantageously laser cut along with the frame 102. While the frame may be formed by laser cutting the frame into the desired shape, the frame may also be formed in other ways, e.g., other types of cutting, molding, 3D printing, individual assembly and attachment, heat treating, and more.


After forming (e.g., by laser cutting), the wire spiral paddles 164 may be shaped into a desired shape/form, e.g., as inwardly-directed helixes or 3D spirals as shown in FIGS. 12-13, and then moved to a pressed relationship with the exterior of the main body 122 of the frame 102. Shaping the helixes inside the frame 102 can facilitate biasing the wire spiral paddles 164 toward the center of the frame or against the exterior of the main body 122 (e.g., if pulled out from the interior and set against the exterior of the frame, e.g., to form a paddle similar to that shown in FIG. 8), as well as providing a means for configuring the force distribution that the paddles exert onto the native leaflets 10, 12. Once laser cutting and shaping or other forming of the helixes is completed, the helixes are wrapped into a cloth comprising a biocompatible material suitable for contacting the leaflets 10, 12. In those embodiments of the prosthetic valve 160 that are intended to be delivered by way of the backward compressed state shown in FIGS. 10-11, the helixes may be wrapped into a cloth pouch or other padding. In embodiment of the prosthetic valve 160 that are to be delivered by way of forward compressed state shown in FIG. 9, the helixes may be stretched into long wavy wires, as described above, and then wrapped into a cloth sleeve.



FIGS. 14-16 illustrate an exemplary embodiment of a prosthetic valve 168 adapted for implantation within the native mitral valve region of the human heart. The prosthetic valve 168 is substantially similar to the prosthetic valve 160, illustrated in FIGS. 6-8, with the exception that the prosthetic valve 168 comprises an interlaced anchoring mechanism 172 configured to receive the native leaflets 10, 12. As best shown in FIGS. 15-16, the interlaced anchoring mechanism 172 may comprise small cuts along the middle section of the main body 122 that allow portions of the frame 102 below the cuts to act as anchors and engage with the leaflets 10, 12, as described herein. The cut can be along a connection point where multiple struts meet.



FIGS. 17 and 18 illustrates respective side and front views of the prosthetic valve 168 crimped into a compressed state suitable for residing within a delivery system capsule. As will be appreciated, an entirety of the prosthetic valve 168 has a relatively small profile when residing within the delivery system capsule, and the anchors do not add to the diameter or profile of the valve 168 (e.g., in contrast to an anchor that overlaps the frame and thereby increases the diameter).


When the portion of the prosthetic valve 168 below the interlaced anchoring mechanism 172 exits the delivery system capsule, the cuts allow the exposed portion of the frame to expand to a profile that is larger than the portion of the remaining with the delivery system capsule. This is a partially deployed configuration. As shown in FIGS. 19-20, the expanded portions of the frame 102 may be engaged with the leaflets 11 and 13, which are representative of native leaflets 10 and 12 so as to anchor the prosthetic valve 168 within the mitral valve region of the heart, even when the main body is not fully expanded. Once the entirety of the prosthetic valve 168 exits the delivery system capsule and fully expands, the leaflets 11 and 13 (or native leaflets 10 and 12) are anchored between the main body 122 and the interlaced anchoring system as shown in FIGS. 21-24. Optionally the anchoring mechanism 172 may be covered in a cloth pouch or other padding.



FIG. 25 illustrates an isometric view of an exemplary embodiment of a prosthetic valve 176 configured to exhibit a relatively small profile when crimped into the compressed state (e.g., the anchors do not add to the profile or diameter because they fit in anchor-receiving regions, shown as a windows in FIG. 25, rather than overlapping the wall of the frame.) The prosthetic valve 176 is substantially similar to the prosthetic valve 100, illustrated in FIG. 6, with the exception that the prosthetic valve 176 comprises anchor-receiving regions or windows 180 that receive anchors/paddles 184 (which include a similar shape to the windows). The windows 180 and the paddles 184 are configured to receive the leaflets 10, 12 there between so as to anchor the prosthetic valve 176 within the mitral valve region of the heart. As will be appreciated, positioning the paddles 184 within the windows 180 significantly reduces the profile of the prosthetic valve 176 when crimped into the compressed state, as compared to a valve that includes anchors or paddles that overlap with the outer wall of the frame, i.e., because the anchors/paddles do not add additional diameter or profile beyond what the frame itself has.


There may be a plurality of openings 2502 defined by the frame 102. When the prosthetic valve 176 is implanted in a native mitral valve, the native leaflets 10, 12 are located between the paddles 184 and the frame 102. In particular, the native leaflets 10, 12 are located between the paddles 184 and two or more of the plurality of openings 2502 of the main body 122. The prosthetic valve 176 may further comprise a skirt 188 disposed within each of the windows 180. The skirts 188 may be configured to keep the paddles 184 circumferentially aligned with the main body 122 of the prosthetic valve when placed into the compressed state. The skirt 188 may be comprised of a biocompatible cloth, Nitinol fiber net, PTFE, ePTFE, or other suitable material having a comparable flexibility and capable of being sutured to cover the windows 180, as shown in FIG. 25. As will be appreciated, the size of the windows 180 and the skirts 188 provides a relatively large contact area between the paddles 184 and the native leaflets 10, 12, and thus local stresses on the leaflets are reduced, and a risk of damage to the leaflets is minimized. Further, in one embodiment the portion of the frame 102 below the windows 180 may be pre-shaped so as to radially protrude outside the circumference of the upper portion of the frame 102. The skirt 188 may be sutured or adhered onto the frame 102 so as to be under continuous tension and thus supply support to the paddles even when the prosthetic valve 176 is in the compressed state. The anchors/paddles 184 may also be covered with cloth/padding so the native leaflet is compressed between the cloth/padding and skirt 188, which will help prevent damage to the native leaflets. The cloth/padding and/or skirt 188 could also be textured or otherwise have a high friction surface to help hold the native leaflets and prevent dislodging the valve.


As stated above, the prosthetic valve 176 has a relatively small profile when crimped into the compressed state suitable for residing within a delivery system capsule. When the paddles 184 exit the delivery system capsule, however, the windows 180 allow the paddles 184 to expand away from the main body 122, such that the native leaflets 10, 12 may be drawn in between the paddles 184 and the main body. Once the entirety of the prosthetic valve 176 exits the delivery system capsule and fully expands, the native leaflets 10, 12 are then anchored between the main body 122 and the paddles 184.



FIG. 26 illustrates an isometric view of an exemplary embodiment of a main body 190 configured to pinch the native leaflets 10, 12 in a direction that is parallel or nearly parallel to the orientation of the leaflets (e.g., general orientation of leaflets indicated by arrow 195 on FIG. 27). The main body 190 comprises frame members 192 that outline anchor-receiving regions that are shaped similar to and can receive anchors/paddles 196 thereunder. The frame members 192 are positioned above corresponding paddles 196, such that windows 200 are disposed there between. In one embodiment, additional frame members similar to frame members 192 could be part of the main body under the frame members 192 and paddles 196, and could form an anchor-receiving region (e.g., a window formed between the additional frame members and the frame members 192 to receiving the anchors/paddles 196). As shown in FIG. 27, the windows 200 are configured to receive the native leaflets 10, 12 such that the paddles 196 and the frame members 192 apply pinching forces (shown in small arrows) in a direction parallel to the leaflets. This can be more secure than pinching forces that are perpendicular to the direction or orientation of the leaflets. In some embodiments, the paddles 196 may be configured to apply pinching forces differently to the anterior leaflet 10 and the posterior leaflet 12. As will be recognized, configuring the paddles 196 to apply pinching forces differently may advantageously accommodate different sizes and shapes that may exist between the leaflets 10, 12.


In some embodiments, portions of the frame members 192 may be pre-shaped to radially protrude outside the circumference of the main body 190, and the paddles 196 may be pre-shaped to protrude radially inside the main body 190. With the frame members 192 protruding oppositely to the paddles 196, the windows 200 may effectively operate as a locking mechanism capable of gripping the native leaflets 10, 12, as shown in FIG. 28. As will be appreciated, any pulling forces on the leaflets 10, 12, such as forces that may otherwise pull the leaflets loose from the windows 200, will pull the frame members 192 and respective paddles 196 closer together, thereby reducing the sizes of the windows 200 and more tightly gripping the leaflets. Thus, the frame members 192 and paddles 196 provide relatively superior leaflet gripping while eliminating any overlap of the paddles and frame members during crimping of the main body 190.


Moreover, the frame members 192 and the paddles 196 may be covered or coated (partially or fully) with a soft material or cloth layer 197 or other padding in order to limit or prevent any damage to the native leaflets 10, 12. As shown in FIG. 29, the soft material or cloth layer 197 may operate as a cushion or padding so as to reduce instances of frictional abrasions or tearing of the leaflet 10, 12. It is envisioned that the soft material layer will add minimally to the profile of the main body 190 in the compresses state.



FIG. 30 illustrates an isometric view of an exemplary embodiment of a prosthetic valve 204 configured to be implanted within the mitral valve region of the heart. The prosthetic valve 204 is substantially similar to the prosthetic valve 100, illustrated in FIG. 6, with the exception that the prosthetic valve 204 comprises ventricular anchors/paddles 208, that are coupled with the frame 102 by way of connection areas 212 (similar connection areas may also be used with other anchors/paddles described herein). As shown in FIG. 30, each of the connection areas 212 may comprise a spring-shaped wire forming a spring-shaped connection that operates as a hinge configured to distribute strain over a relatively large region of the wire during movement between the paddles 208 and the main body 122. Further, the connection areas 212 provide a relatively small coupling between the paddles 208 and the main body 122, thereby giving rise to a relatively reduced profile when the prosthetic valve 204 is in the compressed state. Further, because the connection areas 212 reduce the strain on the connection between the anchors/paddles and the frame, the paddles may be more easily delivered in a forward position or forward compressed state, e.g., the anchors/paddles may be extended forward so that they do not overlap the frame, but extend from an end of the frame. In this way, the profile may be reduced (i.e., because the anchors/paddles) do not overlap the frame) and there is not too much strain at the connection point because connection areas 212 reduce the strain. FIG. 31 shows an exemplary paddle/anchor 208 extended in a forward position. Although the spring-shaped wire illustrated in FIGS. 30-31 comprises a 360-degree spiral, it should be understood that the spring-shaped wire may comprise spirals having more or less than 360 degrees, without limitation, and without deviating beyond the spirit and scope of the present disclosure.



FIG. 32A illustrates a side view of a portion of an exemplary embodiment of a prosthetic valve 220 configured to be implanted within the mitral valve region of the heart. FIG. 32B illustrates a front view of an exemplary embodiment of a prosthetic valve 220 configured to be implanted within the mitral valve region of the heart. A general representation of a frame is shown, but a variety of frame types may be used. The prosthetic valve 220 may be, for example, substantially similar to the prosthetic valves illustrated in FIG. 6 or 30, with the exception that the prosthetic valve 220 comprises anchors or paddles 224 that are coupled with the frame 102 by way of connections or pivoting connections 228. A front view of one paddle 224 is illustrated in FIG. 32B. The paddles 224 may be similar to the paddles 148 in FIG. 6 or paddles 204 illustrated in FIG. 30, with the exception that each of the paddles 224 comprises a first end 232 and a second end 236 that are configured to be slidably received into the pivots 228. The first end 232 generally is longer than the second end 236. Accordingly, the connection/pivot 228 which receives the first end 232 is positioned closer to the ventricular end 130 of the main body 122 than the connection/pivot which receives the second end 236. Similar connections/pivots may be used with other anchors/paddles described herein as well.


As best illustrated in FIG. 33, when the prosthetic valve 220 is in an expanded state, a height difference 240 may exist between the pivots 228 receiving the first and second ends 232, 236 of the paddles 224. The height difference 240 restricts movement of the first and second ends 232, 236 within the pivots, and thus causes the paddles 224 to be pressed against the exterior of the main body 122, as shown in FIGS. 32-33. Thus, in the expanded state of the prosthetic valve 220, the paddles 224 may grip or lock on to the native leaflets 10, 12, as discussed herein, due to the height difference 240 of the pivots 228.


As further illustrated in FIG. 33, portions of the main body 122 where the pivots 228 receive the first ends 232 of the paddles 224 generally comprise differently sized gaps between struts 244 of the main body 122 than portions elsewhere on the main body. As such, the differently sized gaps between the struts 244 of the main body 122 give rise to the height difference 240 in the expanded state of the prosthetic valve 220. As will be appreciated, however, since all of the struts 244 have the same length, all of the gaps between the struts have essentially the same size when the prosthetic valve 220 is in the compressed state. As best illustrated in FIG. 34, when the prosthetic valve 220 is in the compressed state the pivots 228 may become aligned with one another, thereby allowing the paddles 224 to be freely moveable. In the compressed state, therefore, the paddles 224 may be rotated into a forward position or forward compressed state, such that the profile of the prosthetic valve 220 is relatively small, as illustrated in FIG. 34 (e.g., the anchor/paddle does not add to the profile or diameter because it does not overlap the wall of the frame in the forward position).



FIG. 35 illustrates an isometric view of an exemplary embodiment of a prosthetic valve 248 configured to be implanted within the mitral valve region of the heart. The prosthetic valve 248 may be substantially similar to the prosthetic valve 100, illustrated in FIG. 6, with the exception that the prosthetic valve 248 comprises multiple anchors/paddles 252 or multiple thin wires making up one or more anchors/paddles 252 (or making up other anchors/paddles described herein). The valve 248 may include multiple paddles 252 that are thinner in diameter and/or width than the wires comprising the paddles 146, 148 in FIG. 6. In one embodiment, the valve 248 may include 2-10 (e.g., 2-4 or 2-3) thinner paddles 252 on each of two opposite sides of the valve. The paddles 252 may be stacked, parallel, within the boundaries of another, etc. Other anchors/paddles described herein may also be formed from a combination of multiple thinner wires (e.g., braided together, adjacent each other, or otherwise) forming the anchors/paddles. As shown in FIGS. 36-37, experimentation had demonstrated that thinner paddles (e.g., thin wire paddles) exhibit relatively reduced local strain during bending, while coupling multiple thinner wires together is capable of exerting forces substantially equivalent to, or greater than, single larger diameter wires. Also, multiple thinner wires may prevent concentrated compression on the native leaflet and, thus, prevent damage or tearing. In some embodiments, the multiple wire paddles 252 may comprise a grouping wires each characterized by a unique diameter. The paddles 252 may be stacked, parallel, within the boundaries of another, etc. The multiple paddles/wires may be concentrically aligned or the multiple paddles/wires may be braided together or otherwise connected or associated together in any of various configurations suitable for pinching the native leaflets 10, 12, as described herein. It is further envisioned that the number of wires and the various wire thicknesses may be selected and combined together so as to tailor the forces, local strains, and elastic properties exhibited by the multiple wire paddles 252.



FIGS. 38A and 38B illustrate an exemplary embodiment of T-shaped paddles 256 that are configured to facilitate positioning within the mitral valve region of the heart with a minimal risk of damage to the leaflets 10, 12, misplacement of the prosthesis, or chordae tearing/entanglement. The T-shaped paddle 256 comprises a shape memory wire 260 that is restrained in a crimped configuration by a ribbon 264, as shown in FIG. 38A. As will be appreciated, the crimped configuration of the T-shaped paddles 256 is most suitable for delivery into the heart in a forward compressed state, as discussed herein. Once in the mitral valve region of the heart, the direction of the T-shaped paddles 256 may be reversed and the paddles may be engaged with the native leaflets 10, 12. In the illustrated embodiment, an actuation wire (not shown) may be used to pull the ribbon 264 onto a paddle arm 268 so as to release the shape memory wire 260 into an expanded state, as shown in FIG. 38B. Once in the expanded state, the T-shaped paddles 256 may be used to pinch the native leaflets 10, 12, as discussed herein.


Once the ribbon 264 is placed onto the paddle arm 268, as shown in FIG. 38B, the ribbon generally operates a cushion to reduce the risk of abrasion and tissue damage to anatomical structures within the mitral valve region of the heart. The ribbon 264 may be comprised of a biocompatible cloth, Nitinol fiber net, or other suitable material.


In some embodiments, the ribbon may be comprised of a knitted or folded ribbon that may be opened during expanding of the shape memory wire 260. FIGS. 39A and 39B illustrate an exemplary embodiment of T-shaped paddles 272 comprising a folded ribbon 276. The T-shaped paddle 272 is substantially similar to the T-shaped paddle 256, illustrated in FIGS. 38A-38B, with the exception that the T-shaped paddle 272 utilizes the folded ribbon 276 to maintain the shape memory wire 260 in the compressed state shown in FIG. 39A. In one embodiment, the folded ribbon 276 comprises a knitted cloth that may be unstitched during delivery of the prosthetic valve. In one embodiment, the folded ribbon 276 may be peeled during delivery of the prosthetic valve. Once the folded ribbon 276 is peeled, unstitched, or otherwise unfolded, the ribbon remains disposed on the shape memory wire 260 so as to operate as a cushion to reduce the risk of abrasion and tissue damage to the leaflets 10, 12, as well as anatomical structures within the mitral valve region of the heart.


In the embodiments of 38A-39B and other embodiments in which the anchor has a reduced or narrowed profile during delivery and a larger or broader profile once deployed, this type of configuration may be beneficial in positioning the anchors/paddles in regions including chordae. The reduced or narrowed profile may allow the anchor/paddle to avoid or pass through or around chordae more easily, whereas the larger or broader profile may allow for better anchoring and may help prevent the anchor/paddle from slipping past the chordae and out of position.


As will be appreciated, mitral prostheses with paddles that clamp over the native leaflets 10, 12 may require or may be beneficially provided with frame padding so as to avoid trauma to the leaflets. The padding may be thick to help prevent damage, but the thick padding may a significant amount (e.g., 2 mm to 4 mm or more) to the crimp profile of the prosthesis. As will be recognized, the thickest cross-section generally is around the paddles due to the presence of the frame, frame padding, paddle wire, and paddle padding. One approach to reducing the crimp profile of the prosthesis is to install the padding after delivering the prosthesis.



FIGS. 40-41 illustrate an exemplary embodiment of an anchor/paddle 288 and associated padding 284 that may be used with a prosthetic valve (e.g., the valve shown in FIG. 6 or other valves shown or described herein). While anchor/paddle 288 is shown, other anchors/paddles described herein may be used with the padding 284. A padding pocket 284 may be used with the anchor paddle 288 and may be moved into position on a paddle 288 after delivery to the mitral valve region of the heart, e.g., upon deployment but before the paddles 288 are used to pinch the native leaflets 10, 12. In some embodiments, the padding pockets 284 may automatically “jump” onto the paddles 288 when the prosthetic valve 280 is changed from the compressed state to the expanded state, e.g., the padding pocket may be tied to the frame in a way that in the compressed state there is enough slack for the padding pocket to be removed from the anchor/paddle, but when transitioned to the expanded state, the padding pocket may be automatically pulled onto the anchor/paddle as the slack is removed due to the expansion. In some embodiments, such as the embodiments illustrated in FIGS. 40-41, an actuation wire 292, or pull wire, may be incorporated into the prosthetic valve 280. As shown in FIG. 41, the actuation wire 292 facilitates actively pulling the padding pockets 284 onto the paddles 288. In some embodiments, such as the embodiment illustrated in FIG. 40, the padding 284 over the frame 102 may be modular, such that during crimping, the padding 284 may be located separately from the paddles 288, and then the padding 284 may move to the paddles 288 during expanding of the frame 102 so as to provide cushioning between the frame and the native leaflets 10, 12.


While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Further, features described according to one embodiment above may be combined with features of other embodiments described above, even if not expressly described together. To the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well. Therefore, the present disclosure is to be understood as not limited by the specific embodiments described herein, but only by scope of the appended claims.

Claims
  • 1. A prosthetic valve for implantation within a heart, comprising: a main body comprising a frame defining a plurality of openings and a first anchor-receiving region, and being configured to be in a radially compressed state during delivery to the heart; anda first ventricular anchor being coupled to the frame, having a shape corresponding to the first anchor-receiving region such that the first ventricular anchor is located within the first anchor-receiving region of the frame for achieving a reduced-diameter profile of the frame when the frame is in the radially compressed state, and being configured to receive a native leaflet of a native valve of the heart between the first ventricular anchor and two or more of the plurality of openings to anchor the main body within the native valve.
  • 2. The prosthetic valve of claim 1, wherein the first anchor-receiving region forms a first window in the frame.
  • 3. The prosthetic valve of claim 2, further comprising a skirt disposed within the first window.
  • 4. The prosthetic valve of claim 3, wherein the skirt comprises a biocompatible cloth.
  • 5. The prosthetic valve of claim 1, further comprising a second ventricular anchor having a shape similar to a second anchor-receiving region of the frame and being coupled to the frame such that the second ventricular anchor fits within the second anchor-receiving region of the frame.
  • 6. A prosthetic replacement valve for implantation in a defective native mitral valve, comprising: a tubular metallic frame formed with a plurality of openings and a plurality of anchor-receiving regions disposed along a wall of the frame;a plurality of prosthetic leaflets mounted within the frame for regulating a flow of blood in one direction through the prosthetic replacement valve; anda plurality of ventricular anchors coupled to the frame, each ventricular anchor having a shape corresponding to one of the anchor-receiving regions;wherein the ventricular anchors are shaped to be received within the anchor-receiving regions of the frame during delivery of the prosthetic replacement valve to the native mitral valve for reducing a diameter of the prosthetic replacement valve, andwherein the ventricular anchors are configured to receive and surround respective native leaflets of the defective native mitral valve between respective ventricular anchors and two or more of the plurality of openings of the tubular metallic frame when the prosthetic replacement valve is implanted in the defective native mitral valve.
  • 7. The prosthetic valve of claim 6, wherein each anchor-receiving region forms a gap in the wall of the frame and wherein each gap corresponds to a shape of a ventricular anchor.
  • 8. The prosthetic valve of claim 7, wherein the ventricular anchors are adapted for capturing native leaflets of the native mitral valve in a space between the ventricular anchors and the frame during implantation and wherein the native leaflets of the native mitral valve are at least partially pulled into the anchor-receiving regions.
  • 9. The prosthetic valve of claim 7, further comprising a fabric skirt disposed within at least one gap in the wall of the frame for assisting with alignment of at least one ventricular anchor with respect to the wall of the frame.
  • 10. The prosthetic valve of claim 9, wherein the skirt comprises a biocompatible cloth.
RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application No. 62/253,475, filed Nov. 10, 2015, which is hereby incorporated in its entirety.

US Referenced Citations (302)
Number Name Date Kind
3409013 Berry Nov 1968 A
3472230 Fogarty Oct 1969 A
3548417 Kisher Dec 1970 A
3587115 Shiley Jun 1971 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3755823 Hancock Sep 1973 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4106129 Carpentier et al. Aug 1978 A
4222126 Boretos et al. Sep 1980 A
4265694 Boretos et al. May 1981 A
4297749 Davis et al. Nov 1981 A
4339831 Johnson Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4373216 Klawitter Feb 1983 A
4406022 Roy Sep 1983 A
4470157 Love Sep 1984 A
4535483 Klawitter et al. Aug 1985 A
4574803 Storz Mar 1986 A
4592340 Boyles Jun 1986 A
4605407 Black et al. Aug 1986 A
4612011 Kautzky Sep 1986 A
4643732 Pietsch et al. Feb 1987 A
4655771 Wallsten Apr 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
4733665 Palmaz Mar 1988 A
4759758 Gabbay Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4787901 Baykut Nov 1988 A
4796629 Grayzel Jan 1989 A
4829990 Thuroff et al. May 1989 A
4851001 Taheri Jul 1989 A
4856516 Hillstead Aug 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4922905 Strecker May 1990 A
4966604 Reiss Oct 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
5007896 Shiber Apr 1991 A
5026366 Leckrone Jun 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Sammuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5080668 Bolz et al. Jan 1992 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5108370 Walinsky Apr 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5163953 Vince Nov 1992 A
5167628 Boyles Dec 1992 A
5192297 Hull Mar 1993 A
5232446 Arney Aug 1993 A
5266073 Wall Nov 1993 A
5282847 Trescony et al. Feb 1994 A
5295958 Shturman Mar 1994 A
5332402 Teitelbaum Jul 1994 A
5360444 Kusuhara Nov 1994 A
5370685 Stevens Dec 1994 A
5397351 Pavcnik et al. Mar 1995 A
5411055 Kane May 1995 A
5411522 Trott May 1995 A
5411552 Andersen et al. May 1995 A
5443446 Shturman Aug 1995 A
5480424 Cox Jan 1996 A
5500014 Quijano et al. Mar 1996 A
5545209 Roberts et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5549665 Vesely et al. Aug 1996 A
5554185 Block et al. Sep 1996 A
5571175 Vanney et al. Nov 1996 A
5591185 Kilmer et al. Jan 1997 A
5599305 Hermann et al. Feb 1997 A
5607464 Trescony et al. Mar 1997 A
5609626 Quijano et al. Mar 1997 A
5639274 Fischell et al. Jun 1997 A
5665115 Cragg Sep 1997 A
5716417 Girard et al. Feb 1998 A
5728068 Leone et al. Mar 1998 A
5749890 Shaknovich May 1998 A
5756476 Epstein et al. May 1998 A
5769812 Stevens et al. Jun 1998 A
5800508 Goicoechea et al. Sep 1998 A
5840081 Andersen et al. Nov 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855602 Angell Jan 1999 A
5906619 Olson et al. May 1999 A
5925063 Khosravi Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
6027525 Suh et al. Feb 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6132473 Williams et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6174327 Mertens et al. Jan 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6217585 Houser et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6231602 Carpentier et al. May 2001 B1
6245040 Inderbitzen et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6299637 Shaolian Oct 2001 B1
6302906 Goecoechea et al. Oct 2001 B1
6306141 Jervis Oct 2001 B1
6312465 Griffin et al. Nov 2001 B1
6350277 Kocur Feb 2002 B1
6379372 Dehdashtian et al. Apr 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 Di Matteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468660 Ogle Oct 2002 B2
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6527979 Constantz Mar 2003 B2
6540782 Snyders Apr 2003 B1
6569196 Vesely et al. May 2003 B1
6575959 Sarge et al. Jun 2003 B1
6582462 Andersen et al. Jun 2003 B1
6605112 Moll Aug 2003 B1
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6790229 Berreklouw Sep 2004 B1
6830584 Seguin Dec 2004 B1
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
7018406 Seguin et al. Mar 2006 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7276078 Spenser et al. Oct 2007 B2
7276084 Yang et al. Oct 2007 B2
7318278 Zhang et al. Jan 2008 B2
7374571 Pease et al. May 2008 B2
7381210 Zarbatany et al. Jun 2008 B2
7393360 Spenser et al. Jul 2008 B2
7429269 Schwammenthal et al. Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7462191 Spenser et al. Dec 2008 B2
7510575 Spenser et al. Mar 2009 B2
7524330 Berreklouw Apr 2009 B2
7530253 Spenser et al. May 2009 B2
7579381 Dove Aug 2009 B2
7585321 Cribier Sep 2009 B2
7618446 Andersen et al. Nov 2009 B2
7621948 Herrmann et al. Nov 2009 B2
7704222 Wilk et al. Apr 2010 B2
7736327 Wilk et al. Jun 2010 B2
7892281 Seguin et al. Feb 2011 B2
7914575 Guyenot et al. Mar 2011 B2
7993394 Hariton et al. Aug 2011 B2
8007992 Tian et al. Aug 2011 B2
8029556 Rowe Oct 2011 B2
8092520 Quadri Jan 2012 B2
8092521 Figulla et al. Jan 2012 B2
8118866 Herrmann et al. Feb 2012 B2
8167932 Bourang May 2012 B2
8206437 Bonhoeffer et al. Jun 2012 B2
8216174 Wilk et al. Jul 2012 B2
8317858 Straubinger et al. Nov 2012 B2
8398704 Straubinger et al. Mar 2013 B2
8403983 Quadri et al. Mar 2013 B2
8414644 Quadri et al. Apr 2013 B2
8416643 Magee Apr 2013 B2
8449599 Chau et al. May 2013 B2
8460370 Zakay Jun 2013 B2
8652203 Quadri et al. Feb 2014 B2
20010021872 Bailey et al. Sep 2001 A1
20020032481 Gabbay Mar 2002 A1
20020173842 Buchanan Nov 2002 A1
20030050694 Yang et al. Mar 2003 A1
20030100939 Yodfat et al. May 2003 A1
20030158597 Quiachon et al. Aug 2003 A1
20030212454 Scott et al. Nov 2003 A1
20040039436 Spenser et al. Feb 2004 A1
20040092858 Wilson et al. May 2004 A1
20040133263 Dusbabek et al. Jul 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040260389 Case et al. Dec 2004 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050288766 Plain et al. Dec 2005 A1
20060025857 Bergheim et al. Feb 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060142837 Haverkost et al. Jun 2006 A1
20060149350 Patel et al. Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060195134 Crittenden Aug 2006 A1
20060229719 Marquez et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20070005131 Taylor Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070027534 Bergeim et al. Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070066863 Rafiee et al. Mar 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070100439 Cangialosi et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070156224 Cioanta et al. Jul 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070270943 Solem Nov 2007 A1
20080065011 Marchand et al. Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080114442 Mitchell et al. May 2008 A1
20080125853 Bailey et al. May 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080208328 Antocci et al. Aug 2008 A1
20080208332 Lamphere et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080281411 Berreklouw Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090054968 Bonhoeffer et al. Feb 2009 A1
20090054974 McGuckin, Jr. et al. Feb 2009 A1
20090076598 Salahieh et al. Mar 2009 A1
20090112309 Jaramillo et al. Apr 2009 A1
20090138079 Tuval et al. May 2009 A1
20090157175 Benichou Jun 2009 A1
20090164005 Dove et al. Jun 2009 A1
20090171432 Von Segesser et al. Jul 2009 A1
20090171447 Von Segesser et al. Jul 2009 A1
20090171456 Kveen et al. Jul 2009 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090216322 Le et al. Aug 2009 A1
20090222076 Figulla et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240320 Tuval et al. Sep 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20090319037 Rowe et al. Dec 2009 A1
20100016958 St. Goar et al. Jan 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100069852 Kelley Mar 2010 A1
20100131054 Tuval et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
20100168839 Braido Jul 2010 A1
20100174362 Straubinger et al. Jul 2010 A1
20100204781 Alkhatib Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100262231 Tuval et al. Oct 2010 A1
20100312333 Navia et al. Dec 2010 A1
20110015616 Straubinger et al. Jan 2011 A1
20110015729 Jimenez et al. Jan 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110178597 Navia et al. Jul 2011 A9
20110208290 Straubinger et al. Aug 2011 A1
20110208297 Tuval et al. Aug 2011 A1
20110208298 Tuval et al. Aug 2011 A1
20110238159 Guyenot et al. Sep 2011 A1
20110264198 Murray, III et al. Oct 2011 A1
20110288634 Tuval et al. Nov 2011 A1
20110313515 Quadri et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20120035722 Tuval Feb 2012 A1
20120046741 Tuval et al. Feb 2012 A1
20120046742 Tuval et al. Feb 2012 A1
20120101570 Tuval et al. Apr 2012 A1
20120123529 Levi et al. May 2012 A1
20120185039 Tuval et al. Jul 2012 A1
20120197386 Von Segesser et al. Aug 2012 A1
20120209374 Bonhoeffer et al. Aug 2012 A1
20120283823 Bonhoeffer et al. Nov 2012 A1
20120296418 Bonyuet et al. Nov 2012 A1
20120310336 Figulla et al. Dec 2012 A1
20130073035 Tuval et al. Mar 2013 A1
20130079869 Straubinger et al. Mar 2013 A1
20130190862 Pintor et al. Jul 2013 A1
20130197622 Mitra et al. Aug 2013 A1
20130310928 Morriss et al. Nov 2013 A1
20140046433 Kovalsky Feb 2014 A1
20150127100 Braido May 2015 A1
Foreign Referenced Citations (74)
Number Date Country
102639179 Aug 2012 CN
104220027 Dec 2014 CN
2246526 Mar 1973 DE
19532846 Mar 1997 DE
19546692 Jun 1997 DE
19857887 Jul 2000 DE
19907646 Aug 2000 DE
10010074 Oct 2001 DE
10049812 Apr 2002 DE
10049813 Apr 2002 DE
10049814 Apr 2002 DE
10049815 Apr 2002 DE
102006052564 Dec 2007 DE
0103546 Mar 1984 EP
0144167 Jun 1985 EP
0592410 Apr 1994 EP
0597967 May 1994 EP
0850607 Jul 1998 EP
1057460 Dec 2000 EP
1088529 Apr 2001 EP
1469797 Oct 2004 EP
1570809 Sep 2005 EP
1653888 May 2006 EP
1849440 Oct 2007 EP
2788217 Jul 2000 FR
2815844 May 2002 FR
2056023 Mar 1981 GB
1271508 Nov 1986 SU
9117720 Nov 1991 WO
9217118 Oct 1992 WO
93001768 Feb 1993 WO
9724080 Jul 1997 WO
9829057 Jul 1998 WO
9933414 Jul 1999 WO
9940964 Aug 1999 WO
9947075 Sep 1999 WO
0018333 Apr 2000 WO
0041652 Jul 2000 WO
0047139 Aug 2000 WO
0128459 Apr 2001 WO
0135878 May 2001 WO
0149213 Jul 2001 WO
0154624 Aug 2001 WO
0154625 Aug 2001 WO
0162189 Aug 2001 WO
0164137 Sep 2001 WO
0176510 Oct 2001 WO
0222054 Mar 2002 WO
0236048 May 2002 WO
0241789 May 2002 WO
0243620 Jun 2002 WO
0247575 Jun 2002 WO
0249540 Jun 2002 WO
03047468 Jun 2003 WO
05034812 Apr 2005 WO
2005087140 Sep 2005 WO
05102015 Nov 2005 WO
2006014233 Feb 2006 WO
2006034008 Mar 2006 WO
06108090 Oct 2006 WO
06111391 Oct 2006 WO
2006138173 Dec 2006 WO
2008005405 Jan 2008 WO
2008035337 Mar 2008 WO
2008147964 Dec 2008 WO
2008150529 Dec 2008 WO
09024859 Feb 2009 WO
2009091509 Jul 2009 WO
09116041 Sep 2009 WO
2010121076 Oct 2010 WO
2011081997 Jul 2011 WO
2012095455 Jul 2012 WO
2015125024 Aug 2015 WO
2015188066 Dec 2015 WO
Non-Patent Literature Citations (28)
Entry
Int'l. Search Report issued for PCT/US2016/061171, completed Feb. 20, 2017.
Al-Khaja, N., et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery 3:305-311, Jun. 30, 2009.
Almagor, M.D., Yaron, et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits,” Journal of the American College of Cardiology, vol. 16, No. 6, pp. 1310-1314, Nov. 1, 1990; ISSN 3735-1097.
Al Zaibag, Muayed, et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenosis,” British Heart Journal, Jan. 1987, vol. 57, No. 1, pp. 51-53.
Andersen, et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” European Heart Journal (1992), 13, 704-708.
Andersen, Henning Rud, “History of Percutaneous Aortic Valve Prosthesis,” Herz 34 2009 Nr. 5, Urban & Vogel, pp. 343-346, Skejby University Hospital Department of Cardiology, Aarhus, Denmark.
Benchimol, Alberto, et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man,” The American Journal of the Medical Sciences, Jan.-Feb. 1977 vol. 273, No. 1, pp. 55-62.
Dake, Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms, New Engl.J.Med., 1994; 331:1729 34.
Dotter, M.D., Charles T., “Transluminal Treatment of Arteriosclerotic Obstruction,” University of Oregon's Minthorn Memorial Laboratory for Cardiovascular Research through Radiology, Circulation, vol. XXX, Nov. 1964, pp. 654-670.
Kolata, Gina, “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study,” nytimes.com, http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . , Jul. 29, 2009, 2 pages.
Inoue, M.D., Kanji, et al., “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery 87:394-402, 1984.
Lawrence, Jr., M.D., David D., “Percutaneous Endovascular Graft: Experimental Evaluation,” Radiology 1897; 163: 357-360.
Pavcnik, M.D., Ph.D., Dusan, et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology 1992; 183:151-154.
Porstmann, W., et al., “Der Verschluß des Ductus Arteriosus Persistens ohne Thorakotomie,” Thoraxchirurgie Vaskuläre Chirurgie, Band 15, Heft 2, Stuttgart, im Apr. 1967, pp. 199-203.
Rashkind, M.D., William J., “Creation of an Atrial Septal Defect Withoput Thoracotomy,” the Journal of the American Medical Association, vol. 196, No. 11, Jun. 13, 1966, pp. 173-174.
Rashkind, M.D., William J., “Historical Aspects of Interventional Cardiology: Past, Present, Future,” Texas Heart Institute Journal, Interventional Cardiology, pp. 363-367.
Rösch, M.D., Josef, “The Birth, Early Years and Future of Interventional Radiology,” J Vasc Intery Radiol 2003; 14:841-853.
Ross, F.R.C.S., D.N., “Aortic Valve Surgery,” Guy's Hospital, London, pp. 192-197, approximately 1968.
Sabbah, Ph.D., Hani N., et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Journal of Cardiac Surgery, vol. 4, No. 4, pp. 302-309, Dec. 1989; ISSN 0886-0440.
Selby, M.D., J. Bayne, “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems,” Radiology 1990; 176:535-538.
Serruys, P.W., et al., “Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?,” European Heart Journal (1989) 10, 774-782, pp. 37-45, Jun. 13, 1989.
Sigwart, Ulrich, “An Overview of Intravascular Stents: Old and New,” Chapter 48, Textbook of Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815.
Uchida, Barry T., et al., “Modifications of Gianturco Expandable Wire Stents,” AJR:150, May 1988, Dec. 3, 1987, pp. 1185-1187.
Urban, M.D., Philip, “Coronary Artery Stenting,” Editions Médecine et Hygiène, Genève, 1991, pp. 5-47.
Watt, A.H., et al. “Intravenous Adenosine in the Treatment of Supraventricular Tachycardia; a Dose-Ranging Study and Interaction with Dipyridamole,” British Journal of Clinical Pharmacology (1986), 21, 227-230.
Wheatley, M.D., David J., “Valve Prostheses,” Rob & Smith's Operative Surgery, Fourth Edition, pp. 415-424, Butterworths 1986.
EP Search Report dated Jan. 28, 2016 for EP15181583.
EP Search Report dated Feb. 23, 2016 for EP15197122.
Related Publications (1)
Number Date Country
20170128199 A1 May 2017 US
Provisional Applications (1)
Number Date Country
62253475 Nov 2015 US